1. Home
  2. LITB vs TLPH Comparison

LITB vs TLPH Comparison

Compare LITB & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

BUY

Current Price

$2.26

Market Cap

47.2M

ML Signal

BUY

TLPH

Talphera Inc.

HOLD

Current Price

$0.76

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
TLPH
Founded
2007
2005
Country
Singapore
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
37.9M
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
LITB
TLPH
Price
$2.26
$0.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.8K
204.2K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$0.38
52 Week High
$4.17
$1.57

Technical Indicators

Market Signals
Indicator
LITB
TLPH
Relative Strength Index (RSI) 45.07 45.21
Support Level $1.84 $0.74
Resistance Level $2.25 $0.79
Average True Range (ATR) 0.22 0.08
MACD 0.01 0.01
Stochastic Oscillator 57.58 38.98

Price Performance

Historical Comparison
LITB
TLPH

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: